Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;33(4):1180-1188.
doi: 10.1007/s00464-018-6392-9. Epub 2018 Aug 23.

Endoscopic resection of advanced ampullary adenomas: a single-center 14-year retrospective cohort study

Sophia E van der Wiel  1 , Jan-Werner Poley  2 , Arjun D Koch  2 , Marco J Bruno  2
Affiliations

Endoscopic resection of advanced ampullary adenomas: a single-center 14-year retrospective cohort study

Sophia E van der Wiel et al. Surg Endosc. 2019 Apr.

Abstract

Background: Endoscopic ampullectomy has been recognized as a safe and reliable means to resect selective tumors of the ampulla of Vater and is associated with lower morbidity and mortality rates compared to surgical resection. Success rates range from 42 to 92%, with recurrences reported in up to 33%. Studies on endoscopic resection of advanced lesions such as those with intraductal extension of adenoma (IEA) and lateral spreading adenomas (LSA) are limited. We aimed to evaluate the technical success, complications, and recurrence of endoscopic resection of ampullary adenomas, including advanced lesions.

Methods: All patients referred to the Erasmus Medical Center for endoscopic resection of an ampullary lesion were retrospectively identified between 2002 and 2016. Endoscopic success was defined as complete excision of the adenoma, irrespective of the number of attempts, in the absence of recurrence.

Results: We included 87 patients with a median age of 65 years. Of these, 56 patients (64%) had an adenoma confined to the ampulla (ACA), 20 patients (23%) had an LSA, and 11 patients (13%) were treated for an IEA. The median lesion sizes were 24.6 mm, 41.4 mm, and 16.3 mm, respectively (P < 0.001). Complications occurred in 22 patients (25.3%), of which hemorrhage was most prevalent (12.6%), followed by perforation (8.1%). Complications were equally divided (P = 0.874). The median follow-up duration was 21.1 months (12-45.9) for ACA, 14.7 months (4.2-34.5) for LSA, and 5.8 months (3.7-22.0) for IEA (P = 0.051). Endoscopic resection was curative in 87.5% of patients with an ACA, 85% in patients with an LSA, and in only one patient with an IEA (P < 0.001). Recurrence occurred in 10 patients (11.5%) (P = 0.733).

Conclusion: Endoscopic ampullectomy is safe and highly successful in selected patients with an adenoma with or without lateral spreading. Outcomes of endoscopic treatment adenomas with an intraductal extension are less favorable and in these cases surgery should be considered.

Keywords: Ampulla of Vater; Ampullary adenoma; ERCP; Endoscopic ampullectomy; Endoscopic resection.

PubMed Disclaimer

Conflict of interest statement

Dr. J.W. Poley reports personal fees from Boston Scientific, personal fees from Cook Medical and personal fees from Pentax, outside the submitted work. Dr. Bruno reports grants from Boston Scientific, personal fees from Boston Scientific, grants from Cook Medical, personal fees from Cook Medical, grants from 3M and personal fees from 3M, outside the submitted work. S.E. van der Wiel and Dr. A.D. Koch have no conflicts of interest of financial ties to disclose.

Figures

Fig. 1
Fig. 1
Study overview
Fig. 2
Fig. 2
Overview of advanced ampullary adenomas. A LSA. B Intraductal extended adenoma with extension in the common bile duct. C Radial EUS image of the intraductal extended adenoma depicted in B
Fig. 3
Fig. 3
Recurrence-free survival according to endoscopic resection and extension of the adenoma
See this image and copyright information in PMC

References

    1. Scarpa A, Capelli P, Zamboni G, Oda T, Mukai K, Bonetti F, Martignoni G, Iacono C, Serio G, Hirohashi S. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations. Am J Pathol. 1993;142:1163–1172. - PMC - PubMed
    1. Pittayanon R, Imraporn B, Rerknimitr R, Kullavanijaya P. Advances in diagnostic endoscopy for duodenal, including ampullary, adenoma. Dig Endosc. 2014;26(Suppl 2):10–15. doi: 10.1111/den.12244. - DOI - PubMed
    1. Espinel J, Pinedo E, Ojeda V, Del Rio MG. Endoscopic management of adenomatous ampullary lesions. World J Methodol. 2015;5:127–135. doi: 10.5662/wjm.v5.i3.127. - DOI - PMC - PubMed
    1. Di Giorgio A, Alfieri S, Rotondi F, Prete F, Di Miceli D, Ridolfini MP, Rosa F, Covino M, Doglietto GB. Pancreatoduodenectomy for tumors of Vater’s ampulla: report on 94 consecutive patients. World J Surg. 2005;29:513–518. doi: 10.1007/s00268-004-7498-x. - DOI - PubMed
    1. Posner S, Colletti L, Knol J, Mulholland M, Eckhauser F. Safety and long-term efficacy of transduodenal excision for tumors of the ampulla of Vater. Surgery. 2000;128:694–701. doi: 10.1067/msy.2000.108218. - DOI - PubMed

LinkOut - more resources